On March 6, 2018, Jonathan Poole delivered his resignation as Chief Financial Officer of Genocea Biosciences, Inc., effective March 23, 2018, to pursue another professional opportunity. Mr. Poole will assist in the transition of the Chief Financial Officer role until his departure from the Company. The Company is currently conducting a search process for Mr. Poole's replacement and, pending the conclusion of that search, William Clark, President and Chief Executive Officer of the Company, will assume the duties of the Company's principal financial officer and principal accounting officer.